about
5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents.Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides.Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.Antimycobacterial evaluation of pyrazinoic acid reversible derivatives.Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.Pyrazine derivatives: a patent review (June 2012 - present).Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation.Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 - 2015).Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides.Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides.Synthesis, antimycobacterial activity and in vitro cytotoxicity of 5-chloro-N-phenylpyrazine-2-carboxamides.Salicylanilide acetates: synthesis and antibacterial evaluation.Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles.Indole-2-carboxamide derivatives: a patent evaluation of WO2015036412A1.Synthesis of (2E)-2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)prop-2-enoic acid (VUFB 20609) and 2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)propanoic acid (VUFB 20584) as potential antileukotrienic agents.Synthesis and Biological Evaluation of N-Alkyl-3-(alkylamino)-pyrazine-2-carboxamides.Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides.Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage-Preparation, in vitro screening and molecular docking.Synthesis, antimycobacterial, antifungal and photosynthesis-inhibiting activity of chlorinated N-phenylpyrazine-2-carboxamides.Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.Substituted pyrazinecarboxamides as abiotic elicitors of flavolignan production in Silybum marianum (L.) gaertn cultures in vitro.Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.Synthesis and biological activity of 5-alkyl-6-(alkylsulfanyl)- or 5-alkyl-6-(arylsulfanyl)pyrazine-2-carboxamides and corresponding thioamides.Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution.Substituted 5-aroylpyrazine-2-carboxylic acid derivatives: synthesis and biological activity.N-substituted 5-amino-6-methylpyrazine-2,3-dicarbonitriles: microwave-assisted synthesis and biological properties.Vibrational spectroscopic studies and ab initio calculations of a substituted amide of pyrazine-2-carboxylic acid--C12H10ClN3O.Substituted N-phenylpyrazine-2-carboxamides, their synthesis and evaluation as herbicides and abiotic elicitors.Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase.Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase.Substituted pyrazinecarboxamides: synthesis and biological evaluation.Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids.Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors.New potentially active pyrazinamide derivatives synthesized under microwave conditions.Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase.Synthesis of a novel series of non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
P50
Q36393782-0B18368A-5CA4-473D-B59F-67260D439111Q37660998-7D9AADA1-80EC-4666-AD93-E94A25C30E49Q37719566-B9ECF513-E1E2-44D7-905C-AB6923E33679Q37954728-FE63A40D-DD8E-4880-9F48-E191C3967E7BQ38266496-0EDEE42C-66DC-46CF-B04A-A32C615B2FEDQ38293637-847B6C8F-D874-495C-825C-27BE73C68C87Q38718136-470A6C71-5DAD-4FEA-9EDA-350AFCEA8575Q38892242-92DB7358-5BDC-470F-B596-A95696EE86EEQ38910270-42F3FE8A-3A37-4C4D-9E4C-28C001E25C48Q38936430-EAC46698-8F89-480E-8AD4-0C191534AF8BQ39045527-F7F4A2DB-E323-4AB5-9329-1FD3C419D71CQ40095099-B755E521-0183-45BF-A8C7-134951C417A1Q40265709-D52F08AC-438E-4A21-9744-09022738E234Q40356370-AD66C2D0-9282-4ADD-A261-BF7AA104E28DQ40539797-6B446220-C0E1-49D6-9228-C8AF5824A55AQ41719109-1E2BC4D0-46E6-4305-AB19-13C9BBFA642BQ42707632-555CD212-7546-4B6C-A376-81CC37BDDC91Q42722002-78DB1BEA-C46F-4C63-8754-D3F9DFC5EED2Q42754450-4E59A7BC-7838-496E-BAE2-4753D4669DFBQ42760217-55E87ED2-BFFD-449F-A4D4-9A4C635AB05BQ42790376-C5C76A73-4505-41FF-B013-879D7BFC0260Q43170420-5BBB38E4-F578-4771-BAAB-7A9FE885CCEDQ43181308-1BA005F3-E652-4FA6-8C78-D6923F8BF0F1Q43181308-F55BF9B0-9B62-4EBD-BFC7-E3E7865F49C0Q43612984-C7C225F7-8E8B-41D1-B76D-C2F3754C1B7FQ43922581-15610B5F-A8F1-436A-BB71-4E93213CC5BDQ44096275-FB559F4A-7C8B-4342-9777-31EC8A29BF93Q44628194-990394FA-40BC-44FB-BC56-456E35842C74Q45881524-C058DB23-F95E-438C-929E-DB285604F09EQ46692034-91547B66-2191-4F1C-869E-0EACD383AC8AQ46765187-6535C5C2-4CEC-41CC-96B8-AA268C28EB5EQ46804369-6AD70CD0-88B4-4EFC-BE0D-6BA237730488Q46840644-757E3F33-FD0A-4925-A6FD-FF5D526CC350Q46930090-4397905B-6ED0-4D42-8C0F-C3F57E71C0ECQ48113518-D21FF273-99E4-49A1-98A5-8972F5614353Q48135432-C74AB705-00A8-4ADA-BEC8-7EE2ED465909Q51430719-A980288B-E9E6-4EE5-9662-574374D2065AQ52671756-3D138643-7990-4862-8AF8-BF3BBE5299D8Q52678164-7653CDAB-DCEE-49EF-A77D-AF9B595A508EQ52683047-31177A03-6E81-442A-8F7C-C72CE4BD8DEF
P50
description
researcher ORCID 0000-0003-1558-6625
@en
name
Martin Dolezal
@ast
Martin Dolezal
@en
Martin Dolezal
@es
Martin Dolezal
@nl
type
label
Martin Dolezal
@ast
Martin Dolezal
@en
Martin Dolezal
@es
Martin Dolezal
@nl
prefLabel
Martin Dolezal
@ast
Martin Dolezal
@en
Martin Dolezal
@es
Martin Dolezal
@nl
P106
P1153
7006495068
P31
P496
0000-0003-1558-6625